ALFASIGMA ACQUIRES THE ENTIRE SHARE CAPITAL OF SOFAR, AN ITALIAN PHARMACEUTICAL COMPANY
POMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ — Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the
Read MorePOMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ — Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the
Read More